Search

Author/Creator Luscan, Gerald

2. Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials. Issue 1 (December 2016)

Authors:
Vandenberghe, Rik; Rinne, Juha; Boada, Mercè; Katayama, Sadao; Scheltens, Philip; Vellas, Bruno; Tuchman, Michael; Gass, Achim; Fiebach, Jochen; Hill, Derek; Lobello, Kasia; Li, David; McRae, Tom; Lucas, Prisca; Evans, Iona; Booth, Kevin; Luscan, Gerald; Wyman, Bradley; Hua, Lisa; Yang, Lingfeng
Journal:
Alzheimer's research & therapy
Issue:
Volume 8:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials. Issue 6 (28th March 2018)

Authors:
Vermunt, Lisa; Veal, Colin D.; ter Meulen, Lea; Chrysostomou, Charalambos; van der Flier, Wiesje; Frisoni, Giovanni B.; Guessous, Idris; Kivipelto, Miia; Marizzoni, Moira; Martinez‐Lage, Pablo; Molinuevo, José Luis; Porteous, David; Ritchie, Karen; Scheltens, Philip; Ousset, Pierre‐Jean; Ritchie,...
Journal:
Alzheimer's & dementia
Issue:
Volume 14:Issue 6(2018)
Page Start:
837
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies. Issue 1 (December 2016)

Authors:
Ivanoiu, Adrian; Pariente, Jérémie; Booth, Kevin; Lobello, Kasia; Luscan, Gerald; Hua, Lisa; Lucas, Prisca; Styren, Scot; Yang, Lingfeng; Li, David; Black, Ronald; Brashear, H.; McRae, Thomas
Journal:
Alzheimer's research & therapy
Issue:
Volume 8:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗